1. Home
  2. FBGL vs IRIX Comparison

FBGL vs IRIX Comparison

Compare FBGL & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBGL
  • IRIX
  • Stock Information
  • Founded
  • FBGL 1996
  • IRIX 1989
  • Country
  • FBGL Singapore
  • IRIX United States
  • Employees
  • FBGL N/A
  • IRIX N/A
  • Industry
  • FBGL Miscellaneous manufacturing industries
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • FBGL Consumer Discretionary
  • IRIX Health Care
  • Exchange
  • FBGL Nasdaq
  • IRIX Nasdaq
  • Market Cap
  • FBGL 23.6M
  • IRIX 27.5M
  • IPO Year
  • FBGL 2025
  • IRIX 1996
  • Fundamental
  • Price
  • FBGL $1.02
  • IRIX $1.51
  • Analyst Decision
  • FBGL
  • IRIX Hold
  • Analyst Count
  • FBGL 0
  • IRIX 1
  • Target Price
  • FBGL N/A
  • IRIX $2.00
  • AVG Volume (30 Days)
  • FBGL 1.9M
  • IRIX 30.3K
  • Earning Date
  • FBGL 01-01-0001
  • IRIX 03-25-2025
  • Dividend Yield
  • FBGL N/A
  • IRIX N/A
  • EPS Growth
  • FBGL N/A
  • IRIX N/A
  • EPS
  • FBGL 0.04
  • IRIX N/A
  • Revenue
  • FBGL $15,607,369.00
  • IRIX $48,431,000.00
  • Revenue This Year
  • FBGL N/A
  • IRIX N/A
  • Revenue Next Year
  • FBGL N/A
  • IRIX $5.44
  • P/E Ratio
  • FBGL $31.33
  • IRIX N/A
  • Revenue Growth
  • FBGL 25.78
  • IRIX N/A
  • 52 Week Low
  • FBGL $0.87
  • IRIX $1.27
  • 52 Week High
  • FBGL $5.45
  • IRIX $3.65
  • Technical
  • Relative Strength Index (RSI)
  • FBGL N/A
  • IRIX 38.42
  • Support Level
  • FBGL N/A
  • IRIX $1.46
  • Resistance Level
  • FBGL N/A
  • IRIX $1.60
  • Average True Range (ATR)
  • FBGL 0.00
  • IRIX 0.05
  • MACD
  • FBGL 0.00
  • IRIX -0.01
  • Stochastic Oscillator
  • FBGL 0.00
  • IRIX 18.75

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: